21 September 2022

Default text

For reasons of better readability, we use the gender-neutral generic masculine. However, the information expressly refers to all genders.

Print


Press contact
presse@gsk.de
+49 30 203907-7763

Back

GSK Updates
  • 17 May 2023

    GSK Update: German Tax Aspects for Inbound Investments

    Read more
  • 05 May 2023

    GSK Update: Real Estate Investments in Germany from a Tax Perspective

    Read more
  • 04 April 2023

    GSK Update: European Union institutions agree on a standard for EU Green Bonds – Current developments

    Read more

For reasons of better readability, we use the gender-neutral generic masculine. However, the information expressly refers to all genders.

CO2 Neutral